You are not logged in.

Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.

Wang,Y, Li,P, Chen,L, Gao,W, Zeng,F and Kong,LX 2015, Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles., Drug Delivery, vol. 22, no. 2, pp. 191-198, doi: 10.3109/10717544.2013.875603.

Attached Files
Name Description MIMEType Size Downloads

Title Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Author(s) Wang,Y
Li,P
Chen,L
Gao,W
Zeng,F
Kong,LXORCID iD for Kong,LX orcid.org/0000-0001-6219-3897
Journal name Drug Delivery
Volume number 22
Issue number 2
Start page 191
End page 198
Publisher Informa Healthcare
Place of publication England
Publication date 2015-02
ISSN 1521-0464
Keyword(s) HT-29
PLGA-1, 3-diaminopropane-folic acid
nanoparticles
targeting
3-diaminopropane-folic acid
PLGA-1
Summary Abstract The incorporation of a high percentage of targeting molecules into drug delivery system is one of the important methods for improving efficacy of targeting therapeutic drugs to cancer cells. PLGA-based drug delivery carriers with folic acid (FA) as targeting molecule have a low targeting efficiency due to a low FA conjugation ratio. In this work, we fabricated a FA-conjugated PLGA system using a crosslinker 1, 3-diaminopropane and have achieved a high conjugation ratio of 46.7% (mol/mol). The as-prepared PLGA-based biomaterial was used to encapsulate therapeutic drug 5-fluorouracil (5-FU) into nanoparticles. In the in vitro experiments, an IC50 of 5.69 µg/mL has been achieved for 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles on HT-29 cancer cells and is significantly lower than that of 5-FU and 5-FU loaded PLGA nanoparticles which only have an IC50 of 22.9 and 14.17 µg/mL, respectively. The fluorescent microscopy images showed that nanoparticles with FA are largely taken up by HT-29 cancer cells and the targeting nanoparticles have more affinity to cancer cells than the pure drugs and untreated nanoparticles. Therefore, the 1, 3-diaminopropane can facilitate the conjugation of FA to PLGA to form a novel polymer and 5-FU loaded PLGA-1, 3-diaminopropane-folic acid nanoparticles can be a highly efficient system for specific delivery of drugs to cancer cells.
Language eng
DOI 10.3109/10717544.2013.875603
Field of Research 030405 Molecular Medicine
Socio Economic Objective 920102 Cancer and Related Disorders
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2015, Informa Healthcare
Persistent URL http://hdl.handle.net/10536/DRO/DU:30070363

Document type: Journal Article
Collection: Institute for Frontier Materials
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in TR Web of Science
Scopus Citation Count Cited 17 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 172 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Sun, 08 Mar 2015, 21:33:56 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.